Envision Healthcare Corporation (NYSE:EVHC) announced its quarterly earnings data on Monday. The company reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.04, Morningstar.com reports. Envision Healthcare Corporation had a positive return on equity of 5.75% and a negative net margin of 9.16%. The company had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.96 billion. During the same quarter last year, the firm posted $0.34 EPS. The firm’s revenue for the quarter was up 156.7% on a year-over-year basis. Envision Healthcare Corporation updated its Q3 guidance to $0.87-0.83 EPS and its FY17 guidance to $3.35-3.45 EPS.

Shares of Envision Healthcare Corporation (EVHC) traded up 4.81% during mid-day trading on Tuesday, hitting $57.70. The stock had a trading volume of 627,515 shares. The stock’s 50-day moving average is $60.18 and its 200 day moving average is $61.73. The company’s market cap is $6.70 billion. Envision Healthcare Corporation has a 12 month low of $53.12 and a 12 month high of $74.75.

EVHC has been the subject of several recent research reports. Canaccord Genuity reissued a “buy” rating and issued a $86.00 price objective on shares of Envision Healthcare Corporation in a report on Tuesday, April 18th. Jefferies Group LLC set a $75.00 target price on Envision Healthcare Corporation and gave the company a “buy” rating in a report on Friday, April 21st. Zacks Investment Research raised Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, May 2nd. Royal Bank Of Canada reaffirmed a “buy” rating and set a $72.00 target price on shares of Envision Healthcare Corporation in a report on Wednesday, May 3rd. Finally, Mizuho reduced their target price on Envision Healthcare Corporation from $70.00 to $60.00 and set a “neutral” rating for the company in a report on Tuesday, May 30th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $71.89.

In related news, insider Robert Jon Coward sold 1,500 shares of the stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $62.69, for a total transaction of $94,035.00. Following the completion of the sale, the insider now owns 97,863 shares in the company, valued at $6,135,031.47. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.10% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the company. Quantitative Systematic Strategies LLC acquired a new stake in Envision Healthcare Corporation during the first quarter valued at about $373,000. Nisa Investment Advisors LLC boosted its stake in Envision Healthcare Corporation by 14,372.5% in the first quarter. Nisa Investment Advisors LLC now owns 28,945 shares of the company’s stock valued at $1,775,000 after buying an additional 28,745 shares in the last quarter. First United Bank Trust boosted its stake in Envision Healthcare Corporation by 31.2% in the first quarter. First United Bank Trust now owns 9,660 shares of the company’s stock valued at $592,000 after buying an additional 2,295 shares in the last quarter. National Investment Services Inc. WI acquired a new stake in Envision Healthcare Corporation during the first quarter valued at about $1,881,000. Finally, Atria Investments LLC boosted its stake in Envision Healthcare Corporation by 31.3% in the first quarter. Atria Investments LLC now owns 5,380 shares of the company’s stock valued at $330,000 after buying an additional 1,282 shares in the last quarter. Hedge funds and other institutional investors own 64.75% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Envision Healthcare Corporation (EVHC) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/08/07/envision-healthcare-corporation-nyseevhc-announces-quarterly-earnings-results-beats-estimates-by-0-10-eps.html.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Earnings History for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.